Arif Bilal

Track

Insider profile

Performance

Overall performance
2.0
Performance over holding periods
2.0
30 days 90 days 120 days
Average return 0% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Arif Bilal's trades of Sarepta Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-25 2024-06-25
PrS Proposed sale
96,142
24.70
US$1,336,421 		96,142 24.70 US$1,336,421
2024-06-25 2024-06-25
PlS Planned sale
96,502 +33.1%
421.80
US$1,002,833 		96,502 +33.1% 421.80 US$1,002,833
2024-06-25 2024-06-24
PlS Planned sale
40,540 -16.3%
158.91
US$3,681,054 		40,540 -16.3% 158.91 US$3,681,054
2024-06-25 2024-06-24
PlS Planned sale
700 -3.2%
166.10
US$116,270 		700 -3.2% 166.10 US$116,270
2024-06-25 2024-06-24
PlS Planned sale
300 -1.3%
164.61
US$49,383 		300 -1.3% 164.61 US$49,383
2024-06-25 2024-06-24
PlS Planned sale
1,055 -4.5%
163.83
US$172,841 		1,055 -4.5% 163.83 US$172,841
2024-06-25 2024-06-24
PlS Planned sale
5,580 -19.2%
162.31
US$905,690 		5,580 -19.2% 162.31 US$905,690
2024-06-24 2024-06-24
PrS Proposed sale
7,859
160.72
US$1,263,098 		7,859 160.72 US$1,263,098
2024-03-05 2024-03-01
S Sale
457 -1.7%
129.71
US$59,277 		457 -1.7% 129.71 US$59,277
2024-03-05 2024-03-01
S Sale
1,543 -5.4%
128.58
US$198,399 		1,543 -5.4% 128.58 US$198,399
2024-03-01 2024-03-01
PrS Proposed sale
2,000
128.83
US$257,670 		2,000 128.83 US$257,670